newswire, breaking biotechnology and pharma news

Tuesday, October 26, 2010 - Biotech Stock Profile Update; UV Flu Technologies, Inc. (OTCBB: UVFT) New Research Report and New Stock Trading/Chart Video - Biotech Stock Profile Update; UV Flu Technologies, Inc. (OTCBB: UVFT) New Research Report and New Stock Trading/Chart Video

Point Roberts, WA –October 26, 2010 ( Newswire, reports the following updates for showcase biotech stock UV Flu Technologies, Inc. (OTCBB: UVFT) Recent updates to the company profile include a new trading /stock Video by, in addition to and analyst report by Michael Williams. Michael Williams is America’s top authority on small-cap biotech stock picks.

The company profile is available at for interested biotech investors.

UVFT Profile Updates:
UV Flu Technologies Video:

Research Report; Analyst Report by Michael Williams

Full report at

Biotech News Update: A 12-page analyst report on UV Flu Technologies, Inc. (OTCBB: UVFT) will be carried by The Wall Street Journal as an advertising insert in the October 27th edition of the paper. The Wall Street Journal is published by Dow Jones, a world-class publisher of financial and business newspapers, newswires, indexes, magazines, and more. The report has been authored by Michael Williams Market Movers and can also be found online by visiting With the cold and flu season around the corner, the report highlights how UV Flu Technologies’ innovative products and technologies address indoor air quality issues (where bacteria may be present) by killing airborne bacteria and other contaminants at rates exceeding 99.2% on a first-pass basis. UVFT’s flagship product, the Viratech UV-400 air purification system, has been issued a coveted Class II medical listing from the FDA that enables UV Flu Technologies to market the product as a medical device. Details regarding how UVFT’s technology works are identified within the report. The 12-page color report will be featured in the center of home-delivered copies of tomorrow’s (Wednesday’s) Wall Street Journal. The Wall Street Journal has a total average paid circulation of more than 1.5 million, according to the last Newspaper Publisher’s Statement filed in March 2010 with the Audit Bureau of Circulations. For more information on the company featured in the report, call About Michael Williams Market Movers:At Michael Williams Market Movers, we keep our finger on the pulse of change - in commerce, biotech, energy, and digital opportunities way before other investors ever hear about them. To learn more, visit .

About UVFT.OB: UV Flu Technologies, Inc. (OTCBB: UVFT) is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector. The Company manufactures the ViraTech UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. VIRATECH UV-400 is a Class II medical device and is available

UV Flu Technologies (OTCBB: UVFT) is a showcase biotech stock on (please read disclosure and disclaimers)
Visit the showcase page on

Request info:

Research more biotech stocks at the Biotech stocks Directory:

About is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including mining and gold stocks, in addition to global markets including China, India, the Middle East and Australia. is known for its comprehensive stock directories in each sector and sector specific newswires.

About our Biotech investor portal: is a global meeting place for investors and industry following the sector, within Global visitors use the site daily to research the latest news, articles, audio, research reports and our stock directories.

Disclaimer: The following news is paid for by third party on behalf of UV Flu Technologies, Inc., (three thousand per month) is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.

The research report is the content and opinion of Michael Williams at and not the opinion of or related websites. Disclaimer: Disclosure:

Published at - Global research by sectors
If you have any questions regarding information in this press release please contact the company listed in the press release.

No comments:

Post a Comment